42 filings
8-K
BDTX
Black Diamond Therapeutics Inc
12 Mar 24
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:17am
8-K
BDTX
Black Diamond Therapeutics Inc
18 Jan 24
Departure of Directors or Certain Officers
4:04pm
8-K
BDTX
Black Diamond Therapeutics Inc
4 Jan 24
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
8:07am
8-K
BDTX
Black Diamond Therapeutics Inc
13 Dec 23
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM
7:08am
8-K
BDTX
Black Diamond Therapeutics Inc
6 Nov 23
Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:10am
8-K
e36 eu9sgllrlqghkr
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
8-K
hi1 83kxvt5b
11 Aug 23
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:22am
8-K
5cb 0nl13uq3r7
30 Jun 23
Entry into a Material Definitive Agreement
4:03pm
8-K
iw3hjo9t
27 Jun 23
Regulation FD Disclosure
7:11am
8-K
h97ku3 g5x
16 May 23
Submission of Matters to a Vote of Security Holders
5:26pm
8-K
nybp 4vxges0
9 May 23
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:43am
8-K
ex10k6
9 Mar 23
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
7:46am
8-K
k30knyr5sm2jl3x2
19 Dec 22
Black Diamond Therapeutics Announces Changes to Board of Directors
8:20am
8-K
25wbjtz2ufutyj8 zz
12 Dec 22
Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company
8:04am
8-K
1ngoo
8 Nov 22
Black Diamond Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:07am
8-K
lnlnvj8
9 Aug 22
Black Diamond Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:26am
8-K
sgsefkgwrcw
7 Jun 22
Submission of Matters to a Vote of Security Holders
5:14pm
8-K
n2e6phdr1s36sduc36
11 May 22
Black Diamond Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:13pm
8-K
ip810b4 8a2
25 Apr 22
Black Diamond Therapeutics Announces Pipeline Prioritization and Workforce Realignment
9:09am
8-K
21soatttu9ps3ns
7 Apr 22
Black Diamond Therapeutics Appoints Wendy L. Dixon to its Board of Directors
7:13am